Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.18 USD | +2.90% | +8.11% | +7.52% |
May. 08 | Stifel Cuts Price Target on Astrana Health to $45 From $50, Maintains Buy Rating | MT |
May. 07 | Transcript : Astrana Health, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Evolution of the average Target Price on Astrana Health, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Astrana Health, Inc.
Stifel Nicolaus | |
Truist Securities | |
Jefferies & Co. | |
BTIG | |
BofA Securities | |
Lake Street | |
William Blair & Co. | |
Barclays | |
Colliers Securities |
EPS Revisions
- Stock Market
- Equities
- ASTH Stock
- Consensus Astrana Health, Inc.